Paul Matteis Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
36%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
69.2%
Neutral
30.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $40 |
75%
upside
| 1 | +30% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $188 |
42%
upside
| 2 | -0.52% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $35 |
75%
upside
| 1 | +18% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $39 |
134%
upside
| 1 | +42% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $508 |
41%
upside
| 1 | +16% |
0
%
| 11 Dec ‘25 1 month ago |
|
|
|
Hold
Maintained
| $25 |
4%
downside
| 1 | – |
–
| 11 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $28 |
65%
upside
| 1 | +28% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Hold
Maintained
| $3 |
49%
upside
| 1 | – |
–
| 17 Nov ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $61 |
12%
upside
| 2 | +0.25% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Buy
Upgraded
| $202 |
23%
upside
| 1 | +7.2% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Hold
Maintained
| $445 |
1%
upside
| 1 | – |
–
| 4 Nov ‘25 2 months ago |
|